ATE394119T1 - Vakzinzusammensetzung gegen malaria - Google Patents

Vakzinzusammensetzung gegen malaria

Info

Publication number: ATE394119T1
Authority: AT; Austria
Prior art keywords: vaccine composition; composition against; against malaria; malaria; vaccine
Prior art date: 1996-08-02

Application number

AT97940062T

Other languages

English (en)

Inventor

Joseph Cohen

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-02

Filing date

1997-07-31

Publication date

2008-05-15

1997-07-31 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE394119T1 publication Critical patent/ATE394119T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Immunology (AREA)
Mycology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97940062T 1996-08-02 1997-07-31 Vakzinzusammensetzung gegen malaria ATE394119T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9616351.4A GB9616351D0 (en)	1996-08-02	1996-08-02	Vaccine composition

Publications (1)

Publication Number	Publication Date
ATE394119T1 true ATE394119T1 (de)	2008-05-15

Family

ID=10797980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97940062T ATE394119T1 (de)	1996-08-02	1997-07-31	Vakzinzusammensetzung gegen malaria

Country Status (32)

Country	Link
US (2)	US20020172692A1 (de)
EP (2)	EP0957933B1 (de)
JP (1)	JP2000517295A (de)
KR (1)	KR20000029747A (de)
CN (1)	CN1241639C (de)
AP (1)	AP1166A (de)
AR (1)	AR008799A1 (de)
AT (1)	ATE394119T1 (de)
AU (1)	AU706303B2 (de)
BG (1)	BG63290B1 (de)
BR (1)	BR9710913A (de)
CA (1)	CA2262402A1 (de)
CO (1)	CO4650186A1 (de)
CZ (1)	CZ290826B6 (de)
DE (1)	DE69738672D1 (de)
DZ (1)	DZ2283A1 (de)
EA (1)	EA002167B1 (de)
GB (1)	GB9616351D0 (de)
ID (1)	ID17860A (de)
IL (1)	IL128318A (de)
MA (1)	MA24291A1 (de)
MY (1)	MY116128A (de)
NO (1)	NO319844B1 (de)
OA (1)	OA10969A (de)
PE (1)	PE97298A1 (de)
PL (1)	PL188741B1 (de)
SK (1)	SK282438B6 (de)
TR (1)	TR199900195T2 (de)
UA (1)	UA68336C2 (de)
UY (1)	UY24654A1 (de)
WO (1)	WO1998005355A1 (de)
ZA (1)	ZA976815B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9915204D0 (en) *	1999-06-29	1999-09-01	Smithkline Beecham Biolog	Vaccine
US8232255B2 (en)	2002-10-23	2012-07-31	Glaxosmithkline Biologicals S.A.	Methods for vaccinating against malaria
CN1894273B (zh) *	2003-12-01	2011-01-12	明治乳业株式会社	血管紧张素转化酶抑制肽
GB0513421D0 (en) *	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
EA014314B1 (ru) *	2005-08-02	2010-10-29	Новартис Вэксинес Энд Дайэгностикс Срл	Пониженная интерференция между маслосодержащими адъювантами и антигенами, содержащими поверхностно-активные вещества
EA200900032A1 (ru) *	2006-07-18	2011-02-28	Глаксосмитклайн Байолоджикалс С.А.	Вакцины против малярии
GB0614254D0 (en) *	2006-07-18	2006-08-30	Smithkline Beecham Biolog	Vaccine
CA2662064A1 (en)	2006-09-07	2008-03-13	Glaxosmithkline Biologicals S.A.	Method of producing a combination polivirus vaccine
CA2695477A1 (en)	2007-08-13	2009-02-19	Glaxosmithkline Biologicals S.A.	Infant plasmodium falciparum cs vaccines
AU2008339980A1 (en) *	2007-12-21	2009-07-02	Glaxosmithkline Biologicals S.A.	Vaccines for malaria
JP2011507817A (ja)	2007-12-24	2011-03-10	グラクソスミスクラインバイオロジカルズソシエテアノニム	マラリア用ワクチン
US20120015000A1 (en) *	2008-06-30	2012-01-19	David Lanar	Malaria vaccine of self-assembling polypeptide nanoparticles
JP5600170B2 (ja) *	2009-11-05	2014-10-01	アメリカ合衆国	Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍスポロゾイト及び肝臓段階抗原
BR112013004582A2 (pt)	2010-09-27	2016-09-06	Crucell Holland Bv	método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
US20130122038A1 (en)	2011-11-14	2013-05-16	The United States Of America As Represented By The Secretary Of The Department	Heterologous prime-boost immunization using measles virus-based vaccines
US9169304B2 (en)	2012-05-01	2015-10-27	Pfenex Inc.	Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN104338129B (zh) *	2013-07-26	2017-05-24	中国科学院上海巴斯德研究所	雷帕霉素作为疫苗佐剂的用途及制备方法
CN110035770B (zh)	2016-12-07	2023-06-16	葛兰素史密丝克莱恩生物有限公司	新方法
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
IE20190086A1 (en)	2017-05-30	2019-12-25	Glaxosmithkline Biologicals Sa	Novel methods for manufacturing an adjuvant
CA3083078A1 (en)	2017-12-01	2019-06-06	Glaxosmithkline Biologicals Sa	Saponin purification
JP2022535091A (ja)	2019-06-05	2022-08-04	グラクソスミスクラインバイオロジカルズソシエテアノニム	サポニン精製

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3280028D1 (en) *	1981-05-21	1989-12-28	Wellcome Found	Protozoal antigen
ES8800273A1 (es) *	1985-03-28	1987-11-01	Univ New York	Perfeccionamientos en la fabricacion de conjugados de proteinas portadores de antigenos inmunogenicos para vacunas contra la malaria
GB8819209D0 (en) *	1988-08-12	1988-09-14	Research Corp Ltd	Polypeptide & dna encoding same
GB9012580D0 (en) *	1990-06-06	1990-07-25	Univ Nijmegen	Novel protein
FR2679776A1 (fr) *	1991-07-31	1993-02-05	Pasteur Institut	Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
SG48390A1 (en) *	1991-11-16	1998-04-17	Smithkline Beecham Biolog	Hybrid protein between cs from plasmodium and hbs ag
US6169171B1 (en) *	1992-02-27	2001-01-02	Smithkline Beecham Biologicals (S.A.)	Hybrid protein between CS from plasmodium and HBSAG
NZ253137A (en) *	1992-06-25	1996-08-27	Smithkline Beecham Biolog	Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a.
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
AUPM368994A0 (en) *	1994-02-04	1994-02-24	Saramane Pty Ltd	Malaria merozoite antigen subunit vaccine
FR2744724B1 (fr) *	1996-02-14	2002-08-02	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) *	1996-02-14	1997-08-14	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

1996
- 1996-08-02 GB GBGB9616351.4A patent/GB9616351D0/en active Pending
1997
- 1997-07-30 DZ DZ970133A patent/DZ2283A1/fr active
- 1997-07-31 SK SK115-99A patent/SK282438B6/sk unknown
- 1997-07-31 DE DE69738672T patent/DE69738672D1/de not_active Expired - Fee Related
- 1997-07-31 ID IDP972672A patent/ID17860A/id unknown
- 1997-07-31 MY MYPI97003495A patent/MY116128A/en unknown
- 1997-07-31 CN CNB971983607A patent/CN1241639C/zh not_active Expired - Fee Related
- 1997-07-31 AU AU42040/97A patent/AU706303B2/en not_active Ceased
- 1997-07-31 CZ CZ1999292A patent/CZ290826B6/cs not_active IP Right Cessation
- 1997-07-31 JP JP10507631A patent/JP2000517295A/ja active Pending
- 1997-07-31 MA MA24749A patent/MA24291A1/fr unknown
- 1997-07-31 AP APAP/P/1999/001448A patent/AP1166A/en active
- 1997-07-31 CA CA002262402A patent/CA2262402A1/en not_active Abandoned
- 1997-07-31 BR BR9710913A patent/BR9710913A/pt not_active Application Discontinuation
- 1997-07-31 EP EP97940062A patent/EP0957933B1/de not_active Expired - Lifetime
- 1997-07-31 IL IL12831897A patent/IL128318A/en not_active IP Right Cessation
- 1997-07-31 EA EA199900069A patent/EA002167B1/ru not_active IP Right Cessation
- 1997-07-31 EP EP05077131A patent/EP1623720A3/de not_active Withdrawn
- 1997-07-31 ZA ZA9706815A patent/ZA976815B/xx unknown
- 1997-07-31 AT AT97940062T patent/ATE394119T1/de not_active IP Right Cessation
- 1997-07-31 KR KR1019997000855A patent/KR20000029747A/ko not_active Application Discontinuation
- 1997-07-31 UA UA99010527A patent/UA68336C2/uk unknown
- 1997-07-31 WO PCT/EP1997/004326 patent/WO1998005355A1/en active IP Right Grant
- 1997-07-31 TR TR1999/00195T patent/TR199900195T2/xx unknown
- 1997-07-31 PL PL97331424A patent/PL188741B1/pl not_active IP Right Cessation
- 1997-08-01 PE PE1997000672A patent/PE97298A1/es not_active Application Discontinuation
- 1997-08-01 CO CO97044242A patent/CO4650186A1/es unknown
- 1997-08-01 AR ARP970103502A patent/AR008799A1/es not_active Application Discontinuation
- 1997-08-01 UY UY24654A patent/UY24654A1/es not_active IP Right Cessation
1999
- 1999-02-01 NO NO19990464A patent/NO319844B1/no unknown
- 1999-02-02 OA OA9900022A patent/OA10969A/en unknown
- 1999-02-02 BG BG103141A patent/BG63290B1/bg unknown
2001
- 2001-12-18 US US10/024,860 patent/US20020172692A1/en not_active Abandoned
2006
- 2006-08-11 US US11/463,933 patent/US20060292170A1/en not_active Abandoned

Also Published As

Publication number	Publication date
KR20000029747A (ko)	2000-05-25
EP1623720A2 (de)	2006-02-08
IL128318A0 (en)	2000-01-31
UY24654A1 (es)	2001-08-27
ZA976815B (en)	1998-05-11
CZ29299A3 (cs)	1999-06-16
BG103141A (en)	1999-08-31
NO990464D0 (no)	1999-02-01
AU4204097A (en)	1998-02-25
AU706303B2 (en)	1999-06-10
TR199900195T2 (xx)	1999-04-21
CO4650186A1 (es)	1998-09-03
GB9616351D0 (en)	1996-09-11
PL188741B1 (pl)	2005-04-29
BG63290B1 (bg)	2001-09-28
SK11599A3 (en)	2000-03-13
OA10969A (en)	2003-03-04
CN1231613A (zh)	1999-10-13
EP0957933A1 (de)	1999-11-24
SK282438B6 (sk)	2002-02-05
EA199900069A1 (ru)	1999-10-28
NO319844B1 (no)	2005-09-19
EA002167B1 (ru)	2002-02-28
JP2000517295A (ja)	2000-12-26
DZ2283A1 (fr)	2002-12-25
PE97298A1 (es)	1999-02-14
EP1623720A3 (de)	2006-02-22
CA2262402A1 (en)	1998-02-12
MA24291A1 (fr)	1998-04-01
IL128318A (en)	2002-04-21
AP1166A (en)	2003-06-30
CN1241639C (zh)	2006-02-15
WO1998005355A1 (en)	1998-02-12
CZ290826B6 (cs)	2002-10-16
US20020172692A1 (en)	2002-11-21
ID17860A (id)	1998-01-29
UA68336C2 (en)	2004-08-16
MY116128A (en)	2003-11-28
US20060292170A1 (en)	2006-12-28
AP9901448A0 (en)	1999-03-31
BR9710913A (pt)	1999-08-17
AR008799A1 (es)	2000-02-23
NO990464L (no)	1999-02-01
DE69738672D1 (de)	2008-06-19
EP0957933B1 (de)	2008-05-07
PL331424A1 (en)	1999-07-19

Publication	Publication Date	Title
DE69738672D1 (de)	2008-06-19	Vakzinzusammensetzung gegen malaria
NO20004758L (no)	2000-11-08	Vaksinesammensetning
NO20003302L (no)	2000-08-18	Vaksine
DE60045324D1 (de)	2011-01-13	Impfstoffzusammensetzung
DE69933200D1 (de)	2006-10-26	Kombinierte impfstoffzusammensetzungen
BR9711853A (pt)	1999-08-24	Vacinas
ATE197406T1 (de)	2000-11-11	Influenza vaccine
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
DE69729184D1 (de)	2004-06-24	Vakzine gegen clostridium perfringens
NO985460D0 (no)	1998-11-23	Limsammensetning
DE60037357D1 (de)	2008-01-24	Härtbare Zusammensetzung
NO20006191D0 (no)	2000-12-06	Vaksine
ATE135209T1 (de)	1996-03-15	Zusammensetzungen gegen malaria
DE60042148D1 (de)	2009-06-18	Photochromische härtbare zusammensetzung
ID18352A (id)	1998-04-02	Komposisi-komposisi farmasi
DE69737583D1 (de)	2007-05-24	Härtbare Zusammensetzung
DE69718759D1 (de)	2003-03-06	Selbstschäumbare Fluorpolymerzusammensetzung
DE69725482D1 (de)	2003-11-20	Härtbare Siliconzusammensetzungen
DK1023035T3 (da)	2002-09-16	Mundplejemiddel
DE69827335D1 (de)	2004-12-09	Härtbare Zusammensetzung
DE69510840D1 (de)	1999-08-26	Härtbare Organopolysiloxanzusammensetzungen
DE69507744D1 (de)	1999-03-25	Hülle gegen Durchbiegung
PT941100E (pt)	2003-10-31	Composicoes farmaceuticas
DE69527927D1 (de)	2002-10-02	Härtbare Zusammensetzungen
ATE333894T1 (de)	2006-08-15	Vakzine gegen infektiöse bursitis

Legal Events

Date	Code	Title	Description
2008-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties